Apex Labs Granted Israel MoH Approval to Expand Phase 2b Macrodose Psilocybin PTSD Clinical Trial on June 12, 2025 Israel’s Ministry of Health (MoH) approval to add additional sites to APEX SUMMIT–90 160 patient phase 2b macrodose clinical trial: Tel Aviv University (TAU)’s Institute for [...] Read more »